Purpose : To assess the accuracy of drug self-reporting in oocyte donors. Methods : Retrospective chart review of donors at Stanford University. Results : 7% of the donor population had a significant positive urine toxicology screen. Conclusions : Donors may not fully disclose details of drug use, so urine toxicology screening should be considered in this patient population.
As women continue to delay childbirth, an increasing number of women are receiving donated oocytes (1) . However, oocyte donation can often be met with resistance because of recipients' fears associated with anonymity of the process (2) . Recipients and physicians must trust that all information provided by the donors is truthful.
Medical history ranks as one of the most important characteristics that recipients consider when choosing a donor (3). Therefore, information regarding current and past drug use as well as alcohol and tobacco use may be very important to potential recipients. Certain recipients may opt to not use a donor with a history of drug use if this information conflicts with their ethical or religious beliefs (4) .
The majority of donor programs use a combination of questionnaires and screening interviews to obtain pertinent information about drug and alcohol use in potential donors, without the use of mandatory urine drug screening (5) .
We attempted to assess the frequency of current recreational drug use by evaluating all urine toxicology screens in a donor oocyte population. In addition, donors' disclosure statements about current and past drug use were evaluated. From these routine questionnaires the frequency of alcohol and tobacco use was also obtained.
Subjects for this study were drawn from the Stanford University In Vitro Fertilization (IVF) donor egg program. The charts of all donors between November 1998 and August 2002 were evaluated. All patients signed consent forms for their treatment and IRB approval was obtained for review of laboratory and clinical data. Urine toxicology screens from all available participants were evaluated. In addition, medical histories and disclosure statements were examined to determine patients' responses to questions regarding use of medications, tobacco, alcohol, and recreational drugs.
The average age of the patients evaluated was 27 years. Of the 214 toxicology screens available, 19 were positive for one or more substances (8.9%). The positive results were as follows: Acetaminophen 5, Amphetamines 6, Barbiturates 2, Chlorpheniramine 1, Ephedrine 3, Opiates 2, Phentermine 1, Phenobarbital 1, THC 2, Trimethoprim 1 and one unidentified substance. When common substances such as acetaminophen, chlorpheniramine and trimethoprim are excluded, the number of positive urine toxicology screens decreases to 15 (7%).
We reviewed disclosure statements and medical records from donor patients that underwent urine toxicology screening. The only patient who reported use of medications was the patient who tested positive for Phenobarbital. Nineteen patients admitted to past illicit drug use (9%) and none acknowledged current drug use. The drugs that patients had used in the past included marijuana, cocaine, ecstacy, LSD, and valium. There was no significant difference in the number of patients who reported past drug use between patients with significantly positive and negative toxicology screens. There was no significant difference in the age of patients with negative or positive toxicology screens.
Ninety-eight patients reported current alcohol use (46.2%) and none acknowledged past alcohol use. Current and past alcohol use did not vary with result of toxicology screen.
Only 10 patients reported tobacco use, seven currently (3.3%) and three in the past (1.4%). There was no significant difference in either past or current tobacco use between the patients with positive or negative toxicology screens.
When questioned, none of our donors admitted to present drug use. However, our data showed that 7% of our donor population had significant positive urine toxicology screens. This is similar to the rate of current drug use in the United States in the year 2001, which was 7.1% (6) Our donor patients reported less past drug use (9%) than the general American population in 2000 (38.9%). Also, the rate of current alcohol use in our patients (46.2%) is similar to the national rate (48.3%) in 2001. However, the rate of current cigarette smoking was much less than the general population (3.3% vs 24.9%).
Many drugs may potentially have a negative impact on fertility (7) . Although ASRM guidelines recommend obtaining a personal history from potential donors, they do not require mandatory drug screening. It is reasonable for IVF programs to screen all potential oocyte donors with urine toxicology screens, as the donors may not fully disclose details of drug use (8, 9) .
